Litcius/Paper detail

NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances

Xuesong Wu, Liang Sun, Fangying Xu

2023Pharmaceuticals38 citationsDOIOpen Access PDF

Abstract

The transcription factor nuclear factor-κB (NF-κB) plays a complicated role in multiple tumors. Mounting evidence demonstrates that NF-κB activation supports tumorigenesis and development by enhancing cell proliferation, invasion, and metastasis, preventing cell death, facilitating angiogenesis, regulating tumor immune microenvironment and metabolism, and inducing therapeutic resistance. Notably, NF-κB functions as a double-edged sword exerting positive or negative influences on cancers. In this review, we summarize and discuss recent research on the regulation of NF-κB in cancer cell deaths, therapy resistance, and NF-κB-based nano delivery systems.

Topics & Concepts

Cancer researchAngiogenesisNF-κBMetastasisTumor microenvironmentTranscription factorCarcinogenesisImmune systemMedicineCancerBiologyTumor cellsImmunologyInflammationInternal medicineBiochemistryGeneNF-κB Signaling PathwaysCancer Mechanisms and TherapyImmune cells in cancer
NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances | Litcius